Literature DB >> 20652295

The illness and everyday living: close interplay of psychopathological syndromes and psychosocial functioning in chronic schizophrenia.

Daniela Schaub1, Martin Brüne, Elisabeth Jaspen, Frank-Gerald Pajonk, Hans-Werner Bierhoff, Georg Juckel.   

Abstract

The interaction of psychopathological states and psychosocial functioning determine the long-term course of schizophrenia and its treatment. To be able to achieve this interplay better, exact assessment of psychosocial functioning is needed besides measurement of psychopathology. Using the Personal and Social Performance (PSP) Scale, examination of the association between psychosocial functioning and psychopathology was conducted in a sample of 103 patients with chronic schizophrenia. Rating instruments were in addition Global Assessment of Functioning Scale and Social and Occupational Functioning Assessment Scale, as well as Positive and Negative Syndrome Scale (PANSS), Clinical Global Impression Scale, and Mini-ICF-APP-Rating for Mental Disorders (Mini-ICF-APP). Besides good psychometric properties for the PSP scale in this chronic sample, we found, as expected, significant associations between the two relevant outcome domains: results showed significant negative correlations between PSP and PANSS. Findings prove the close interplay between social functioning and psychopathology in the chronic course of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20652295     DOI: 10.1007/s00406-010-0122-1

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  19 in total

1.  [Quality of life--what it means to me... Results of a survey among schizophrenic patients].

Authors:  M C Angermeyer; A Holzinger; H Matschinger
Journal:  Psychiatr Prax       Date:  1999-03

2.  The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model.

Authors:  Mark van der Gaag; Tonko Hoffman; Mila Remijsen; Ron Hijman; Lieuwe de Haan; Berno van Meijel; Peter N van Harten; Lucia Valmaggia; Marc de Hert; Anke Cuijpers; Durk Wiersma
Journal:  Schizophr Res       Date:  2006-05-26       Impact factor: 4.939

3.  [For and against: is quality of life a meaningful indicator of outcome? For].

Authors:  Reinhold Kilian
Journal:  Psychiatr Prax       Date:  2006-10

Review 4.  Social functioning as an outcome measure in schizophrenia studies.

Authors:  T Burns; D Patrick
Journal:  Acta Psychiatr Scand       Date:  2007-10-17       Impact factor: 6.392

5.  To what extent does symptomatic improvement result in better outcome in psychotic illness? UK700 Group.

Authors:  J van Os; C Gilvarry; R Bale; E van Horn; T Tattan; I White; R Murray
Journal:  Psychol Med       Date:  1999-09       Impact factor: 7.723

6.  [The "Mini-ICF-Rating for Mental Disorders (Mini-ICF-P)". A short instrument for the assessment of disabilities in mental disorders].

Authors:  M Linden; S Baron
Journal:  Rehabilitation (Stuttg)       Date:  2005-06       Impact factor: 1.113

7.  Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder.

Authors:  Alex Hofer; Maria A Rettenbacher; Christian G Widschwendter; Georg Kemmler; Martina Hummer; W Wolfgang Fleischhacker
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-11-29       Impact factor: 5.270

Review 8.  Defining and measuring clinical effectiveness in the treatment of schizophrenia.

Authors:  Henry A Nasrallah; Steven D Targum; Rajiv Tandon; Jeffrey S McCombs; Ruth Ross
Journal:  Psychiatr Serv       Date:  2005-03       Impact factor: 3.084

9.  Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia.

Authors:  Georg Juckel; Daniela Schaub; Nina Fuchs; Ute Naumann; Idun Uhl; Henning Witthaus; Ludger Hargarter; Hans-Werner Bierhoff; Martin Brüne
Journal:  Schizophr Res       Date:  2008-07-01       Impact factor: 4.939

Review 10.  Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life.

Authors:  Martin Lambert; Dieter Naber
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

View more
  15 in total

1.  [PSP Scale: German version of the Personal and Social Performance Scale: valid instrument for the assessment of psychosocial functioning in the treatment of schizophrenia].

Authors:  D Schaub; G Juckel
Journal:  Nervenarzt       Date:  2011-09       Impact factor: 1.214

2.  The Portuguese version of the Personal and Social Performance Scale (PSP): reliability, validity, and relationship with cognitive measures in hospitalized and community schizophrenia patients.

Authors:  Sofia Brissos; Filipa Palhavã; João Gama Marques; Susana Mexia; Ana Lisa Carmo; Manuel Carvalho; Cátia Dias; João Data Franco; Rita Mendes; Pedro Zuzarte; Ana Isabel Carita; Andrew Molodynski; Maria Luisa Figueira
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-07-08       Impact factor: 4.328

3.  Is personal and social functioning associated with subjective quality of life in schizophrenia patients living in the community?

Authors:  Sofia Brissos; Vicent Balanzá-Martinez; Vasco Videira Dias; Ana Isabel Carita; Maria Luisa Figueira
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-08       Impact factor: 5.270

4.  Subtle deficits of cognitive theory of mind in unaffected first-degree relatives of schizophrenia patients.

Authors:  Christiane Montag; Kathrin Neuhaus; Anja Lehmann; Katja Krüger; Isabel Dziobek; Hauke R Heekeren; Andreas Heinz; Jürgen Gallinat
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-09-04       Impact factor: 5.270

5.  Family Functioning in First-Episode and Chronic Psychosis: The Role of Patient's Symptom Severity and Psychosocial Functioning.

Authors:  Katerina Koutra; Sofia Triliva; Theano Roumeliotaki; Maria Basta; Christos Lionis; Alexandros N Vgontzas
Journal:  Community Ment Health J       Date:  2015-08-19

6.  Validation of the Italian version of Mini-ICF-APP, a short instrument for rating activity and participation restrictions in psychiatric disorders.

Authors:  M Balestrieri; M Isola; R Bonn; T Tam; A Vio; M Linden; E Maso
Journal:  Epidemiol Psychiatr Sci       Date:  2012-09-19       Impact factor: 6.892

7.  The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study.

Authors:  Alessandro Rossi; Silvana Galderisi; Paola Rocca; Alessandro Bertolino; Armida Mucci; Paola Rucci; Dino Gibertoni; Eugenio Aguglia; Mario Amore; Ileana Andriola; Antonello Bellomo; Massimo Biondi; Gaetano Callista; Anna Comparelli; Liliana Dell'Osso; Massimo Di Giannantonio; Andrea Fagiolini; Carlo Marchesi; Palmiero Monteleone; Cristiana Montemagni; Cinzia Niolu; Giuseppe Piegari; Federica Pinna; Rita Roncone; Paolo Stratta; Elena Tenconi; Antonio Vita; Patrizia Zeppegno; Mario Maj
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-07-06       Impact factor: 5.270

8.  Assessment of functioning in patients with schizophrenia and schizoaffective disorder with the Mini-ICF-APP: a validation study in Italy.

Authors:  Federica Pinna; Andrea Fiorillo; Massimo Tusconi; Beatrice Guiso; Bernardo Carpiniello
Journal:  Int J Ment Health Syst       Date:  2015-10-31

9.  Psychiatrists' perceptions of the clinical importance, assessment and management of patient functioning in schizophrenia in Europe, the Middle East and Africa.

Authors:  Philip Gorwood; Tom Burns; Georg Juckel; Alessandro Rossi; Luis San; Ludger Hargarter; Andreas Schreiner
Journal:  Ann Gen Psychiatry       Date:  2013-03-26       Impact factor: 3.455

10.  Towards a framework for treatment effectiveness in schizophrenia.

Authors:  Georg Juckel; Andrea de Bartolomeis; Philip Gorwood; Sergey Mosolov; Luca Pani; Alessandro Rossi; Julio Sanjuan
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-24       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.